| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| GOLDSMITH MARK A | President and Chief Executive Officer, Director | C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY | /s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith | 18 Dec 2025 | 0001246842 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVMD | Common Stock | Sale | $1,182,526 | -15,394 | -6.2% | $76.82 | 232,469 | 16 Dec 2025 | Direct | F1, F2 |
| holding | RVMD | Common Stock | 67,424 | 16 Dec 2025 | Trust | F3 | |||||
| holding | RVMD | Common Stock | 67,424 | 16 Dec 2025 | Trust | F4 | |||||
| holding | RVMD | Common Stock | 570,050 | 16 Dec 2025 | Trust | F5 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. |
| F2 | Includes 168,763 restricted stock units. |
| F3 | Held by Jonathan Goldsmith Revocable Trust. |
| F4 | Held by Rebecca Goldsmith Revocable Trust. |
| F5 | Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust. |
President and Chief Executive Officer